SEC Form 4 · accession 0001235802-18-000144
Xtant Medical Holdings, Inc. · XTNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kathie J. Lenzen
Officer — Chief Financial Officer
Period of report
Sep 15, 2018
Accepted (ET)
Sep 18, 2018 · 4:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001453593
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.000001 par value | holding | — | — | — | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $4.66 | Sep 15, 2018 | A | 130,000 | A | — | Sep 15, 2028 | Common Stock | 130,000 | 130,000 | D |
Explanation of responses
- F1This option vests with respect to 32,500 shares on each of September 15, 2019, September 15, 2020, September 15, 2021 and September 15, 2022, subject to such Reporting Person's continued employment with Xtant Medical Holdings, Inc.